LOGIN
Thromboprophylaxis with enoxaparin for 20 days postdischarge reduced incidence of DVT
August 2013
Thromboprophylaxis with enoxaparin for 20 days postdischarge reduced incidence of DVT
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Extended-Duration Thromboprophylaxis With Enoxaparin After Arthroscopic Surgery of the Anterior Cruciate Ligament: A Prospective, Randomized, Placebo-Controlled Study
Arthroscopy. 2007 Jul;23(7):696-702Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
175 patients who have undergone arthroscopic ACL surgery and had been administered enoxaparin starting 12-18 hours post-op until 3-8 days post-op in the hospital, were randomized to either self-administer enoxaparin for 20 additional days postdischarge, or self-administer a placebo for 20 days postdischarge. The results indicated that postdischarge throbmoprophylaxis for an extended period of 20 d...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.